The proteasome is involved in angiogenesis

被引:114
作者
Oikawa, T
Sasaki, T
Nakamura, M
Shimamura, M
Tanahashi, N
Omura, S
Tanaka, K
机构
[1] Tokyo Metropolitan Inst Med Sci Rinshoken, Dept Canc Therapeut, Bunkyo Ku, Tokyo 1130021, Japan
[2] Kitasato Inst, Minato Ku, Tokyo 108, Japan
关键词
D O I
10.1006/bbrc.1998.8604
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The proteasome is a recently identified intracellular protease whose catalytic active site is a threonine residue and has been shown to play key roles in a variety of important intracellular events, including cell cycle progression, the antigen-presenting pathway, and apc,ptosis. However, its biological significance in multicellular organisms is still largely unknown because of lack of experimental systems for its study. Here we verified potential involvement of the proteasome in angiogenesis using lactacystin, a specific proteasome inhibitor. Lactacystin treatment resulted in almost complete prevention of in vivo neovascularization in the developing chick embryo chorioallantoic membrane. It also inhibited vascular endothelial tube formation on Matrigel, a model for in vitro angiogenesis, in a concentration-dependent fashion. Moreover, it prevented production of plasminogen activator, an important protease responsible for induction of angiogenesis, by endothelial cells, which correlated well with its suppression of intracellular proteasome activity. Our studies suggest that the proteasome operates in the process of angiogenesis, a phenomenon essential in important physiological and pathological settings. (C) 1998 Academic Press.
引用
收藏
页码:243 / 248
页数:6
相关论文
共 29 条
[1]   MEDROXYPROGESTERONE ACETATE, AN ANTI-CANCER AND ANTI-ANGIOGENIC STEROID, INHIBITS THE PLASMINOGEN-ACTIVATOR IN BOVINE ENDOTHELIAL-CELLS [J].
ASHINOFUSE, H ;
TAKANO, Y ;
OIKAWA, T ;
SHIMAMURA, M ;
IWAGUCHI, T .
INTERNATIONAL JOURNAL OF CANCER, 1989, 44 (05) :859-864
[2]   ANGIOGENESIS INHIBITION - A REVIEW [J].
AUERBACH, W ;
AUERBACH, R .
PHARMACOLOGY & THERAPEUTICS, 1994, 63 (03) :265-311
[3]   How tumors become angiogenic [J].
Bouck, N ;
Stellmach, V ;
Hsu, SC .
ADVANCES IN CANCER RESEARCH, VOL 69, 1996, 69 :135-174
[4]   INTEGRIN ALPHA(V)BETA(3) ANTAGONISTS PROMOTE TUMOR-REGRESSION BY INDUCING APOPTOSIS OF ANGIOGENIC BLOOD-VESSELS [J].
BROOKS, PC ;
MONTGOMERY, AMP ;
ROSENFELD, M ;
REISFELD, RA ;
HU, TH ;
KLIER, G ;
CHERESH, DA .
CELL, 1994, 79 (07) :1157-1164
[5]  
COCKERILL GW, 1995, INT REV CYTOL, V159, P113, DOI 10.1016/S0074-7696(08)62106-3
[6]   Structure and functions of the 20S and 26S proteasomes [J].
Coux, O ;
Tanaka, K ;
Goldberg, AL .
ANNUAL REVIEW OF BIOCHEMISTRY, 1996, 65 :801-847
[7]   A BETA-LACTONE RELATED TO LACTACYSTIN INDUCES NEURITE OUTGROWTH IN A NEUROBLASTOMA CELL-LINE AND INHIBITS CELL-CYCLE PROGRESSION IN AN OSTEOSARCOMA CELL-LINE [J].
FENTEANY, G ;
STANDAERT, RF ;
REICHARD, GA ;
COREY, EJ ;
SCHREIBER, SL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (08) :3358-3362
[8]   INHIBITION OF PROTEASOME ACTIVITIES AND SUBUNIT-SPECIFIC AMINO-TERMINAL THREONINE MODIFICATION BY LACTACYSTIN [J].
FENTEANY, G ;
STANDAERT, RF ;
LANE, WS ;
CHOI, S ;
COREY, EJ ;
SCHREIBER, SL .
SCIENCE, 1995, 268 (5211) :726-731
[9]   ANGIOGENESIS IN CANCER, VASCULAR, RHEUMATOID AND OTHER DISEASE [J].
FOLKMAN, J .
NATURE MEDICINE, 1995, 1 (01) :27-31
[10]   Tumor angiogenesis and tissue factor [J].
Folkman, J .
NATURE MEDICINE, 1996, 2 (02) :167-168